DK1161521T3 - Transplantation af hæmatopoietiske celler - Google Patents

Transplantation af hæmatopoietiske celler

Info

Publication number
DK1161521T3
DK1161521T3 DK00905194T DK00905194T DK1161521T3 DK 1161521 T3 DK1161521 T3 DK 1161521T3 DK 00905194 T DK00905194 T DK 00905194T DK 00905194 T DK00905194 T DK 00905194T DK 1161521 T3 DK1161521 T3 DK 1161521T3
Authority
DK
Denmark
Prior art keywords
transplantation
hematopoietic cells
disease
treatment
stem cells
Prior art date
Application number
DK00905194T
Other languages
Danish (da)
English (en)
Inventor
Jack Price
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Application granted granted Critical
Publication of DK1161521T3 publication Critical patent/DK1161521T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00905194T 1999-02-24 2000-02-23 Transplantation af hæmatopoietiske celler DK1161521T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904281.4A GB9904281D0 (en) 1999-02-24 1999-02-24 Transplantation
PCT/GB2000/000636 WO2000050568A2 (en) 1999-02-24 2000-02-23 Transplantation of haematopoietic cells

Publications (1)

Publication Number Publication Date
DK1161521T3 true DK1161521T3 (da) 2003-06-16

Family

ID=10848438

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00905194T DK1161521T3 (da) 1999-02-24 2000-02-23 Transplantation af hæmatopoietiske celler

Country Status (20)

Country Link
EP (1) EP1161521B1 (ko)
JP (1) JP4716575B2 (ko)
KR (1) KR20020000216A (ko)
CN (1) CN1636053A (ko)
AT (1) ATE237680T1 (ko)
AU (1) AU762763B2 (ko)
CA (1) CA2361401A1 (ko)
CZ (1) CZ20012651A3 (ko)
DE (1) DE60002185T2 (ko)
DK (1) DK1161521T3 (ko)
ES (1) ES2193938T3 (ko)
GB (1) GB9904281D0 (ko)
HK (1) HK1041284B (ko)
HU (1) HUP0105168A3 (ko)
NO (1) NO20014091D0 (ko)
PL (1) PL350297A1 (ko)
PT (1) PT1161521E (ko)
RU (1) RU2216336C2 (ko)
SK (1) SK11232001A3 (ko)
WO (1) WO2000050568A2 (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
PT1183035E (pt) * 1999-05-14 2015-03-04 Ford Henry Health System Transplante de medula óssea para tratamento de acidente vascular cerebral
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
US7687505B2 (en) * 2002-01-14 2010-03-30 Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
CN1738654A (zh) * 2002-11-15 2006-02-22 株式会社产学连携机构九州 器官再生方法
ES2294650T3 (es) 2004-09-30 2008-04-01 Reneuron Limited Linea celular.
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US7569545B2 (en) * 2005-05-20 2009-08-04 Academia Sinica Methods of increasing neurotrophic factor expression
CN101495623B (zh) 2006-03-24 2013-09-11 儿童医疗中心有限公司 调节造血干细胞生长的方法
AU2007329725B2 (en) 2006-10-20 2013-05-23 Children's Medical Center Corporation Method to enhance tissue regeneration
US8791128B2 (en) 2008-09-16 2014-07-29 University Of Central Florida Research Foundation, Inc. Compositions for treating or delaying the onset of hair loss
US9051548B2 (en) 2009-02-03 2015-06-09 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
US9056085B2 (en) 2009-02-03 2015-06-16 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
EP3384912B1 (en) * 2011-04-20 2020-11-11 The Regents of The University of California Method for combined conditioning and chemoselection in a single cycle
CA2857640C (en) 2011-12-02 2021-11-16 Fate Therapeutics, Inc. Enhanced stem cell composition
WO2013082241A2 (en) 2011-12-02 2013-06-06 Fate Therapeutics, Inc. Improved methods of treating ischemia
EP2968416A4 (en) 2013-03-15 2016-08-17 Fate Therapeutics Inc BIOLOGICAL ACTIVITY TESTING OF CELLS FOR A THERAPEUTIC POTENTIAL
RU2647429C1 (ru) * 2017-02-06 2018-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Биомедицинский клеточный препарат
RU2720002C1 (ru) * 2018-12-28 2020-04-23 Андрей Степанович БРЮХОВЕЦКИЙ Биомедицинский клеточный продукт для лечения нервных болезней и психических расстройств, способ его получения и его применение
CN114934072B (zh) * 2022-05-18 2023-10-20 华中科技大学同济医学院附属协和医院 一种人心脏瓣膜间质细胞系的永生化构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
JPH07504331A (ja) * 1992-03-04 1995-05-18 システミックス，インコーポレイティド 造血幹細胞の培養およびその遺伝子工学
IL122752A (en) * 1995-06-27 2001-07-24 Boehringer Ingelheim Kg Stable preparations for creating propellant-free sprays
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
AU740709B2 (en) * 1996-08-19 2001-11-15 University Of Massachusetts Embryonic or stem-like cell lines produced by cross species nuclear transplanta tion

Also Published As

Publication number Publication date
KR20020000216A (ko) 2002-01-05
WO2000050568A3 (en) 2000-12-07
CA2361401A1 (en) 2000-08-31
AU762763B2 (en) 2003-07-03
CN1636053A (zh) 2005-07-06
EP1161521B1 (en) 2003-04-16
PT1161521E (pt) 2003-08-29
AU2682100A (en) 2000-09-14
JP4716575B2 (ja) 2011-07-06
HUP0105168A3 (en) 2003-12-29
NO20014091L (no) 2001-08-23
ATE237680T1 (de) 2003-05-15
DE60002185D1 (de) 2003-05-22
HUP0105168A2 (hu) 2002-05-29
RU2216336C2 (ru) 2003-11-20
NO20014091D0 (no) 2001-08-23
EP1161521A2 (en) 2001-12-12
PL350297A1 (en) 2002-12-02
WO2000050568A2 (en) 2000-08-31
GB9904281D0 (en) 1999-04-21
JP2002537406A (ja) 2002-11-05
HK1041284A1 (en) 2002-07-05
ES2193938T3 (es) 2003-11-16
SK11232001A3 (sk) 2002-01-07
CZ20012651A3 (cs) 2002-01-16
HK1041284B (zh) 2003-10-03
DE60002185T2 (de) 2003-12-18

Similar Documents

Publication Publication Date Title
DK1161521T3 (da) Transplantation af hæmatopoietiske celler
GT199600026A (es) Isotiazolonas
WO2003105725A3 (en) ARTIFICIAL CORNEA
SE9900100D0 (sv) New compounds
SG129236A1 (en) Somatic pluripotent cells
ATE262859T1 (de) Multifokale phakische intraokularlinse
YU401A (sh) Sredstva sa antidepresivnim dejstvom
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
DE602004029986D1 (en) Stent
IL148505A0 (en) Progressive additions lenses
DE50004995D1 (de) Permanente amniozyten-zelllinie, ihre herstellung und verwendung zur herstellung von gentransfervektoren
TW367365B (en) An improved method for obtaining plant somatic embryos about the somatic embryo suspension cultures and pro-embryogenic mass suspension cultures
ATE262854T1 (de) Prothese zur herniareparatur
ID24391A (id) Perlengkapan pengepasan rambut tiruan dan metoda penggunaannya
BR9914899A (pt) Uso de (r)-tofisopam opticamente puro para o tratamento e a prevenção de distúrbios de ansiedade e composição do mesmo
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
DE59406417D1 (de) Bauteilsatz zur herstellung eines wurzelraumschutzes
DE60043888D1 (de) Oberfläche für zellkultur
CA95616S (en) Tanned hide
AR027349A1 (es) Derivados de amidas heterociclicas
ES2134280T3 (es) Procedimiento de produccion de pilocarpina.
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
SE9704458D0 (sv) Anläggning samt förfarande vid en sådan, del 2
ES1039077U (es) Estropajo mejorado.
IT1286947B1 (it) Misuratore dell'accrescimento dell'ampiezza del fusto di piante